Cited by 2,480Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 242 of the 245 references it cites were found in a registry or an index, and 1 are not checked yet.

Neurodegenerative Tauopathies

Lee, Virginia M-Y, Goedert, Michel, Trojanowski, John Q·2001·Annual Review of Neuroscience

DOI 10.1146/annurev.neuro.24.1.1121

Open this paper in CoChat — free account

Abstract

The defining neuropathological characteristics of Alzheimer's disease are abundant filamentous tau lesions and deposits of fibrillar amyloid beta peptides. Prominent filamentous tau inclusions and brain degeneration in the absence of beta-amyloid deposits are also hallmarks of neurodegenerative tauopathies exemplified by sporadic corticobasal degeneration, progressive supranuclear palsy, and Pick's disease, as well as by hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Because multiple tau gene mutations are pathogenic for FTDP-17 and tau polymorphisms appear to be genetic risk factors for sporadic progressive supranuclear palsy and corticobasal degeneration, tau abnormalities are linked directly to the etiology and pathogenesis of neurodegenerative disease. Indeed, emerging data support the hypothesis that different tau gene mutations are pathogenic because they impair tau functions, promote tau fibrillization, or perturb tau gene splicing, thereby leading to formation of biochemically and structurally distinct aggregates of tau. Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that additional genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies. Although these and other hypothetical mechanisms of neurodegenerative tauopathies remain to be tested and validated, transgenic models are increasingly available for this purpose, and they…

Integrity signals

Registry

Crossref · 10.1146/annurev.neuro.24.1.1121

Cites

242 of 243 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citation
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citation

Show all 245 references

Research works printed but not linked: 19

Arrasate M, 1997, Am. J. Pathol., 151, 1115
Brion JP, 1985, Arch. Biol., 95, 229
Feany MB, 1995, Am. J. Pathol., 146, 1388
10.1007/s004010050296 · DOI
10.1128/mcb.9.4.1381 · DOI
Hong M, Trojanowski JQ, Lee VM-Y. 2000.Tau-based neurofibrillary lesions.InNeurodegenerative Dementias, ed. CM Clark, JQ Trojanowski, pp. 161–75. New York: McGraw Hill
10.1007/s004010050140 · DOI
Ksiezak-Reding H, 1994, Am. J. Pathol., 145, 1496
10.1007/s004010050138 · DOI
Pickering-Brown S, 2000, Ann. Neurol., 48, 806, 10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1 · DOI
Rebeiz J, 1967, Trans. Am. Neurol. Assoc., 92, 23
Rep. Work Group Frontotemporal Dementia Pick's Disease. 2001. Clinical and neuropathological diagnosis of frontotemporal dementias.Neurobiol. Aging.In press
Shin RW, 1991, Lab. Invest., 64, 693
Snow AD, 1990, Am. J. Pathol., 137, 1253
10.1002/1531-8249(200012)48:6<939::aid-ana17>3.3.co;2-t · DOI
Trojanowski JQ, 1994, Am. J. Pathol., 144, 449
10.1007/s004010050126 · DOI
Wilhelmsen KC, 1994, Am. J. Hum. Genet., 55, 1159
Wilson DM, 1997, Am. J. Pathol., 150, 2181

Sorted by citations

Items 601–700 of 1,023

High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe
Schultz, C., Ghebremedhin, E., Tredici, K. D., Rüb, U., & Braak, H. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00113-1 · Cited by 92
Targeting tau: clinical trials and novel therapeutic approaches
VandeVrede, L., Boxer, A. L., & Polydoro, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134919 · Cited by 90
Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
Lee, L., Dale, E., Staniszewski, A., Zhang, H., Saeed, F., Sakurai, M., Fà, M., Orozco, I. J., Michelassi, F. E., Akpan, N., et al. (2014) · Scientific Reports · doi:10.1038/srep07190 · Cited by 91
Divergent phosphorylation pattern of tau in P301L tau transgenic mice
Deters, N. A., Ittner, L. M., & Götz, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06318.x · Cited by 91
Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer’s disease
Jacobsen, J. S., Reinhart, P. H., & Pangalos, M. N. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.612 · Cited by 94
FTDP-17 Mutations Compromise the Ability of Tau to Regulate Microtubule Dynamics in Cells
Bunker, J. M., Kamath, K., Wilson, L., Jordan, M. A., & Feinstein, S. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509420200 · Cited by 90
Co-Localization of Glycogen Synthase Kinase-3 with Neurofibrillary Tangles and Granulovacuolar Degeneration in Transgenic Mice
Ishizawa, T., Sahara, N., Ishiguro, K., Kersh, J. S., McGowan, E. M., Lewis, J. M., Hutton, M. L., Dickson, D. W., & Yen, S.-H. C. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63465-7 · Cited by 90
The Cytoskeleton in Oligodendrocytes: Microtubule Dynamics in Health and Disease
Richter-Landsberg, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9017-7 · Cited by 89
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
Pritchard, S. M., Dolan, P. J., Vitkus, A., & Johnson, G. V. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01273.x · Cited by 89
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89
Protein Nuclear Magnetic Resonance under Physiological Conditions
Pielak, G. J., Li, C., Miklos, A. C., Schlesinger, A. P., Slade, K. M., Wang, G.-F., & Zigoneanu, I. G. (2008) · Biochemistry · doi:10.1021/bi8018948 · Cited by 92
HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila
Xiong, Y., Zhao, K., Wu, J., Xu, Z., Jin, S., & Zhang, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207586110 · Cited by 90
A validated antibody panel for the characterization of tau post-translational modifications
Ercan-Herbst, E., Eid, S., Weber, C., Kowalski, A., Bichmann, M., Behrendt, A., Matthes, F., Krauß, S., Reinhardt, P., Fulle, S., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0229-1 · Cited by 92
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
Kim, A. Y., Jerdi, S. A., MacDonald, R., & Triggle, C. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399121 · Cited by 99
MicroRNA-29b Regulates the Expression Level of Human Progranulin, a Secreted Glycoprotein Implicated in Frontotemporal Dementia
Jiao, J., Herl, L. D., Farese, R. V., & Gao, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010551 · Cited by 89
Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice
Pennanen, L., Welzl, H., D’Adamo, P., Nitsch, R. M., & Götz, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.020 · Cited by 89
Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines
Xia, D., Li, C., & Götz, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.017 · Cited by 91
Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro
Qureshi, H. Y., & Paudel, H. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178905 · Cited by 90
Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain
Sahara, N., Maeda, S., Yoshiike, Y., Mizoroki, T., Yamashita, S., Murayama, M., Park, J. ‐., Saito, Y., Murayama, S., & Takashima, A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21417 · Cited by 90
Disruption of the MAP1B-related Protein FUTSCH Leads to Changes in the Neuronal Cytoskeleton, Axonal Transport Defects, and Progressive Neurodegeneration inDrosophila
da Cruz, A. B., Schwärzel, M., Schulze, S., Niyyati, M., Heisenberg, M., & Kretzschmar, D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1004 · Cited by 89
Protein Aggregation and Dysfunction of Autophagy-Lysosomal Pathway: A Vicious Cycle in Lysosomal Storage Diseases
Monaco, A., & Fraldi, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00037 · Cited by 91
Tau-induced neurodegeneration: mechanisms and targets
Beharry, C., Cohen, L. S., Di, J., Ibrahim, K., Briffa-Mirabella, S., & Alonso, A. D. C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1414-z · Cited by 92
Phosphoproteomic Analysis of Human Brain by Calcium Phosphate Precipitation and Mass Spectrometry
Xia, Q., Cheng, D., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Peng, J. (2008) · Journal of Proteome Research · doi:10.1021/pr8000496 · Cited by 90
Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease
Fang, F., Yang, W., Florio, J. B., Rockenstein, E. M., Spencer, B. J., Orain, X., Dong, S. X., Li, H., Chen, X., Sung, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04232-4 · Cited by 94
Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
Dutta, D., Jana, M., Paidi, R. K., Majumder, M., Raha, S., Dasarathy, S., & Pahan, K. (2023) · Journal of Clinical Investigation · doi:10.1172/jci161987 · Cited by 87
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
Wagner, J., Krauß, S., Shi, S., Ryazanov, S., Steffen, J., Miklitz, C., Leonov, A., Kleinknecht, A., Göricke, B., Weishaupt, J. H., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1483-3 · Cited by 87
Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels
He, Y., Du, M., Gao, Y. L., Liu, H., Wang, H., Wu, X., & Wang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076495 · Cited by 87
Peroxynitrite induces Alzheimer‐like tau modifications and accumulation in rat brain and its underlying mechanisms
Zhang, Y., Xu, Y., Liu, Y., Yin, J., Li, H., Wang, Q., & Wang, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5223com · Cited by 86
Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
Kumar, S., Tepper, K., Kaniyappan, S., Biernat, J., Wegmann, S., Mandelkow, E., Müller, D. J., & Mandelkow�, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554725 · Cited by 88
Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: Implications of autophagy promotion
Shimada, K., Motoi, Y., Ishiguro, K., Kambe, T., Matsumoto, S., Itaya, M., Kunichika, M., Mori, H., Shinohara, A., Chiba, M., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.050 · Cited by 87
Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease
Бачурин, С. О. (2002) · Medicinal Research Reviews · doi:10.1002/med.10026 · Cited by 91
Update on the Neuropathological Diagnosis of Frontotemporal Dementias
Trojanowski, J. Q., & Dickson, D. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1123 · Cited by 87
Self-citation
Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation
Rankin, C. A., Sun, Q., & Gamblin, T. C. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.012 · Cited by 95
Characteristics of Tau Oligomers
Ren, Y., & Sahara, N. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00102 · Cited by 86
14-3-3 Binds to and Mediates Phosphorylation of Microtubule-associated Tau Protein by Ser9-phosphorylated Glycogen Synthase Kinase 3β in the Brain
Yuan, Z., Agarwal-Mawal, A., & Paudel, H. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308298200 · Cited by 91
Altered longevity‐assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death
Pehar, M., O’Riordan, K. J., Burns‐Cusato, M., Andrzejewski, M. E., del Alcazar, C. R. G., Bürger, C., Scrable, H. J., & Puglielli, L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00547.x · Cited by 89
G-Protein Coupled Receptors and Tau-different Roles in Alzheimer’s Disease
Chidambaram, H., & Chinnathambi, S. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.019 · Cited by 87
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 89
Phosphorylation of microtubule‐associated protein tau by AMPK‐related kinases
Yoshida, H., & Goedert, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07523.x · Cited by 85
Self-citation
Genetic Modulation of Tau Phosphorylation in the Mouse
Brich, J., Shie, F., Howell, B. W., Li, R., Tus, K., Wakeland, E. K., Jin, L., Mumby, M. C., Churchill, G. A., Herz, J., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00187.2003 · Cited by 84
Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs
Attems, J., Quass, M., & Jellinger, K. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0146-9 · Cited by 84
The role of tau in Alzheimer's disease
Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00002-0 · Cited by 85
Self-citation
Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions
Grune, T., Botzen, D., Engels, M., Voß, P., Kaiser, B., Jung, T., Grimm, S., Ermak, G., & Davies, K. J. A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.008 · Cited by 85
Oxidative Stress in Alzheimer's and Parkinson's Diseases: Insights from the YeastSaccharomyces cerevisiae
Pimentel, C., Batista-Nascimento, L. S., Rodrigues‐Pousada, C., & Menezes, R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/132146 · Cited by 86
Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2
Latorre, E., Torregrossa, R., Wood, M. E., Whiteman, M., & Harries, L. W. (2018) · Aging · doi:10.18632/aging.101500 · Cited by 87
Comparative insight into surfactants mediated amyloidogenesis of lysozyme
Chaturvedi, S. K., Khan, J. M., Siddiqi, M. K., Alam, P., & Khan, R. H. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.11.053 · Cited by 84
Modulation of Amyloid Protein Fibrillation by Synthetic Polymers: Recent Advances in the Context of Neurodegenerative Diseases
Ghosh, P., & De, P. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01021 · Cited by 84
Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
Madsen, D. A., Schmidt, S. I., Blaabjerg, M., & Meyer, M. (2021) · Cells · doi:10.3390/cells10020283 · Cited by 85
Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses
Meng, J. X., Zhang, Y., Saman, D., Haider, A. M., De, S., Sang, J. C., Brown, K., Jiang, K., Humphrey, J., Julian, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30461-x · Cited by 84
First transgenic rat model developing progressive cortical neurofibrillary tangles
Filipčík, P., Žilka, N., Bugos, O., Kučerák, J., Koson, P., Novák, P., & Novák, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.015 · Cited by 90
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates
Vega, I. E., Cui, L., Propst, J. A., Hutton, M. L., Lee, G. S., & Yen, S.-H. C. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.015 · Cited by 84
T1ρ MRI of Alzheimer's disease
Borthakur, A., Sochor, M., Davatzikos, C., Trojanowski, J. Q., & Clark, C. M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.030 · Cited by 84
Self-citation
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
Pathways linking Aβ and tau pathologies
LaFerla, F. M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380993 · Cited by 85
DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
Wang, S., Shi, X.-D., Li, H., Pang, P., Pei, L., Shen, H., & Lu, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0008-y · Cited by 83
Tau monomer encodes strains
Sharma, A. M., Thomas, T. L., Woodard, D. R., Kashmer, O. M., & Diamond, M. I. (2018) · eLife · doi:10.7554/elife.37813 · Cited by 80
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Wang, Y. T., & Edison, P. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0962-7 · Cited by 86
Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation
Lu, J., Zhang, S., Ma, X., Jia, C., Liu, Z., Huang, C., Liu, C., & Li, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012284 · Cited by 80
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
Leuzy, A., Pascoal, T. A., Strandberg, O. T., Insel, P. S., Smith, R. A., Mattsson, N., Benedet, A. L., Cho, H., Lyoo, C. H., Joie, R. L., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05401-4 · Cited by 89
Deregulation of brain insulin signaling in Alzheimer’s disease
Chen, Y., Deng, Y., Zhang, B., & Gong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1408-x · Cited by 82
Sequential phosphorylation of tau protein by cAMP‐dependent protein kinase and SAPK4/p38δ or JNK2 in the presence of heparin generates the AT100 epitope
Yoshida, H., & Goedert, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04052.x · Cited by 87
Self-citation
Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau
Aoyagi, H., Hasegawa, M., & Tamaoka, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611876200 · Cited by 83
Side Chain-dependent Stacking Modulates Tau Filament Structure
Margittai, M., & Langen, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605336200 · Cited by 84
Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics
Aluise, C. D., Sowell, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M. J., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 83
Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells
Hu, J.-Y., Zhang, D.-L., Liu, X., Li, X.-S., Cheng, X., Chen, J., Du, H., & Liang, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.022 · Cited by 81
Preclinical Evaluation of18F-JNJ64349311, a Novel PET Tracer for Tau Imaging
Declercq, L., Rombouts, F. J. R., Koole, M. J. B., Fierens, K., Mariën, J., Langlois, X., Andrés, J. I., Schmidt, M. E., Macdonald, G. J., Moechars, D., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185199 · Cited by 84
Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R
van Herpen, E., Rosso, S. M., Serverijnen, L., Yoshida, H., Breedveld, G. J., van de Graaf, R., Kamphorst, W., Ravid, R., Willemsen, R., Dooijes, D., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10721 · Cited by 83
Self-citation
Stimulatory effect of α‐synuclein on the tau‐phosphorylation by GSK‐3 β
Kawakami, F., Suzuki, M., Shimada, N., Kagiya, G., Ohta, E., Tamura, K., Maruyama, H., & Ichikawa, T. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08389.x · Cited by 82
Effects of melatonin on wortmannin-induced tau hyperphosphorylation
yan-qiu, D., Xu, G., Duan, P., Zhang, Q., & Wang, J. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00102.x · Cited by 82
Pre‐mRNA splicing modulations in senescence
Meshorer, E., & Soreq, H. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00005.x · Cited by 82
Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons – implications for Alzheimer's disease
Härtig, W., Stieler, J., Boerema, A. S., Wolf, J., Schmidt, U., Weißfuß, J., Bullmann, T., Strijkstra, A. M., & Arendt, T. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05250.x · Cited by 83
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy
Morris, H. R., Gibb, G., Katzenschlager, R., Wood, N. W., Hanger, D. P., Strand, C., Lashley, T., Daniel, S. E., Lees, A. J., Anderton, B. H., et al. (2002) · Brain · doi:10.1093/brain/awf109 · Cited by 83
The Dynamics and Turnover of Tau Aggregates in Cultured Cells
Guo, J., Buist, A., Soares, A. C., Callaerts, K., Calafate, S., Stevenaert, F., Daniels, J. P., Zoll, B. E., Crowe, A., Brunden, K. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712083 · Cited by 83
Self-citation
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
Abreha, M. H., Dammer, E. B., Ping, L., Zhang, T., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · PROTEOMICS · doi:10.1002/pmic.201800108 · Cited by 82
The Neurotoxic Role of Extracellular Tau Protein
Sebastián‐Serrano, Á., de Diego-García, L., & Díaz-Hernández, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040998 · Cited by 85
MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy
Wang, X., Li, W., Marcus, J., Pearson, M. S., Song, L., Smith, K. D. B., Terracina, G., Lee, J. A., Hong, K.-L. K., Lu, S. X., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266122 · Cited by 85
Nanoscale-alumina induces oxidative stress and accelerates amyloid beta (Aβ) production in ICR female mice
Shah, S. A., Yoon, G. H., Ahmad, A., Ullah, F., Amin, F. U., & Kim, M. O. (2015) · Nanoscale · doi:10.1039/c5nr03598h · Cited by 81
Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism
Hagen, N., Hans, M., Hartmann, D., Swandulla, D., & van Echten‐Deckert, G. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.7 · Cited by 81
Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions
Dütting, S., Brachs, S., & Mielenz, D. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-2 · Cited by 80
Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam (ALS/PDC)
Judith Miklossy, A., Steele, J. C., Yu, S. Y., McCall, S. A., Sandberg, G. D., McGeer, E. G., & McGeer, P. L. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0439-2 · Cited by 81
Activation of PAR-1 Kinase and Stimulation of Tau Phosphorylation by Diverse Signals Require the Tumor Suppressor Protein LKB1
Wang, J.-W., Imai, Y., & Lu, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5094-06.2007 · Cited by 80
“Several kinases and phosphatases have been shown to regulate tau phosphorylation in vitro (Lee et al., 2001).”
Background
The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases
Qu, L., Pan, C., He, S., Lang, B., Gao, G.-D., Wang, X., & Wang, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00121 · Cited by 84
A possible link between astrocyte activation and tau nitration in Alzheimer's disease
Reyes, J. F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Guillozet-Bongaarts, A. L., Berry, R., & Binder, L. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.005 · Cited by 85
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 61
Separation of phosphoprotein isotypes having the same number of phosphate groups using phosphate‐affinity SDS‐PAGE
Kinoshita, E., Kinoshita‐Kikuta, E., Matsubara, M., Yamada, S., Nakamura, H., Shiro, Y., Aoki, Y., Okita, K., & Koike, T. (2008) · PROTEOMICS · doi:10.1002/pmic.200800243 · Cited by 80
The Peptidyl-prolyl Isomerase Pin1 Up-regulation and Proapoptotic Function in Dopaminergic Neurons
Ghosh, A., Saminathan, H., Kanthasamy, A., Anantharam, V., Jin, H., Sondarva, G. V., Harischandra, D. S., Qian, Z., Rana, A., & Kanthasamy, A. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444224 · Cited by 80
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 81
Protective effect of crocin on acrolein-induced tau phosphorylation in the rat brain
Rashedinia, M., Lari, P., Abnous, K., & Hosseinzadeh, H. (2015) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2015-2029 · Cited by 79
Interaction of 14-3-3ζ with Microtubule-Associated Protein Tau within Alzheimer’s Disease Neurofibrillary Tangles
Qureshi, H. Y., Li, T., MacDonald, R., Cho, C., Leclerc, N. M., & Paudel, H. K. (2013) · Biochemistry · doi:10.1021/bi400442d · Cited by 83
Animal models reveal role for tau phosphorylation in human disease
Götz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. C., & Ittner, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.008 · Cited by 82
Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer′s Disease: A Therapeutic Target
Gong, C., Liu, F., Grundke, I., & Iqbal, K. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31825 · Cited by 81
FTDP-17 Tau Mutations Induce Distinct Effects on Aggregation and Microtubule Interactions
Combs, B., & Gamblin, T. C. (2012) · Biochemistry · doi:10.1021/bi3010818 · Cited by 79
Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
Venkatramani, A., & Panda, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.120 · Cited by 84
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions
Cairns, N. J., Perry, R. H., Jaros, E., Burn, D. J., McKeith, I. G., Lowe, J. S., Holton, J. L., Rossor, M. N., Skullerud, K., Duyckaerts, C. J., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00100-9 · Cited by 79
Drugs targeting alzheimer’s disease: Some things old and some things new
Michaelis, M. L. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035840 · Cited by 78
Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity
Hill, E., Karikari, T. K., Moffat, K. G., Richardson, M. J. E., & Wall, M. J. (2019) · eNeuro · doi:10.1523/eneuro.0166-19.2019 · Cited by 83
Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review
Rashed, A. A., Rahman, A. Z. A., & Rathi, D.-N. G. (2021) · Molecules · doi:10.3390/molecules26041107 · Cited by 78
The genetics of neurodegenerative diseases
Hardy, J., & Orr, H. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03979.x · Cited by 81
Tau Protein and Adult Hippocampal Neurogenesis
Fuster-Matanzo, A., Llorens-Martı́n, M., Jurado‐Arjona, J., Ávila, J., & Hernández, F. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00104 · Cited by 85
The molecular basis of frontotemporal dementia
Neumann, M., Tolnay, M., & Mackenzie, I. R. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001136 · Cited by 80

Authors: Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q.
Affiliations: MRC Laboratory of Molecular Biology (GB)
ORCID: Lee, Virginia M-Y
Goedert, Michel
Trojanowski, John Q
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2001-03
Volume: 24
Issue: 1
Pages: 1121-1159
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev.neuro.24.1.1121
OpenAlex: W4230565756
Semantic Scholar: 8eb6355272daf41b8da72a5b18a4d8c67d8509cc
Cited by: 2,480
References: 245
Citations by year: 2026: 60 · 2025: 81 · 2024: 102 · 2023: 112 · 2022: 133 · 2021: 130 · 2020: 126 · 2019: 107 · 2018: 114 · 2017: 94 · 2016: 100 · 2015: 115 · 2014: 99 · 2013: 100 · 2012: 92
FWCI: 9.22
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: tau protein, tau gene mutations, FTDP-17, progressive supranuclear palsy, corticobasal degeneration, Pick's disease, Alzheimer's disease, tau fibrillization, genetic risk factors, transgenic animal models, neurodegeneration
MeSH terms: Animals, Brain, Brain Diseases, Dementia, Humans, Neurofibrillary Tangles, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurodegenerative Tauopathies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks